Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures.

× No keyword cloud information.

8 in total

1. Small-animal PET demonstrates brain metabolic change after using bevacizumab in a rat model of cerebral ischemic injury.

Authors: Ying Dong; Fahuan Song; Jianjuan Ma; Xuexin He; Said Amer; Weizhong Gu; Mei Tian
Journal: Neurosci Bull Date: 2014-09-28 Impact factor: 5.203

2. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.

Authors: Sarosh R Irani; Jeffrey M Gelfand; Brianne M Bettcher; Neel S Singhal; Michael D Geschwind
Journal: JAMA Neurol Date: 2014-07-01 Impact factor: 18.302

Review 3. Autoimmune encephalopathies.

Authors: Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal: Ann N Y Acad Sci Date: 2014-10-14 Impact factor: 5.691

4. Evaluation of positive and negative predictors of seizure outcomes among patients with immune-mediated epilepsy: a meta-analysis.

Authors: Divyanshu Dubey; Zehra Farzal; Ryan Hays; L Steven Brown; Steven Vernino
Journal: Ther Adv Neurol Disord Date: 2016-07-04 Impact factor: 6.570

8. Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review.

Authors: Yuou Teng; Ting Li; Zhizhong Yang; Mingwan Su; Jingnian Ni; Mingqing Wei; Jing Shi; Jinzhou Tian
Journal: Front Neurol Date: 2022-01-12 Impact factor: 4.003

8 in total

Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures.

1. Small-animal PET demonstrates brain metabolic change after using bevacizumab in a rat model of cerebral ischemic injury.

2. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy.

Review 3. Autoimmune encephalopathies.

4. Evaluation of positive and negative predictors of seizure outcomes among patients with immune-mediated epilepsy: a meta-analysis.

5. CNS autoimmunity: new findings and pending issues.

6. Limbic encephalitis and related cortical syndromes.

7. Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome.

8. Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review.